SANDY, Utah--(BUSINESS WIRE)--Today, 401GO, a fully-owned 401(k) platform, announced $33 million in Series B funding. The round was led by Centana Growth Partners, with participation from existing ...

Productivity growth slowed down a bit in the first quarter of the year, increasing just 0.8%, according to the Bureau of Labor Statistics. But looking at the same data year-on-year, productivity was a ...

Video Education With Clinical Genetic Testing Coordinators for the Rapid Evaluation of Patients With Cancers: Real-World Evidence First-line osimertinib demonstrated significantly longer median OS ...

Image model releases are driving growth for AI mobile apps, generating 6.5x more downloads than traditional model updates, according to a new report from app intelligence provider Appfigures. For ...

New York, USA, April 30, 2026 (PinionNewswire) — Reo.Dev, a company focused on developer-first go-to-market intelligence, is bringing attention to a critical gap in how modern software buying ...

Caterpillar raises 2026, long-term revenue forecasts, trims tariff impact First-quarter profit aided by strong construction, power equipment sales Caterpillar seen as bellwether for global industrial ...

Trillions of dollars will move from older generations to their heirs over the next two decades. Amid this great wealth transfer, sudden inheritances can cause problems for heirs — and the advisors who ...

The conflict in the Middle East is having a negative impact on Europe's largest economy, with soaring energy prices and supply chain shocks hammering sentiment. Germany's economy minister this week ...

Some subscribers prefer to save their log-in information so they do not have to enter their User ID and Password each time they visit the site. To activate this function, check the 'Keep me signed in' ...

BOSTON--(BUSINESS WIRE)--HubSpot today announced new and updated products at its Spring 2026 Spotlight, including the introduction of HubSpot AEO, expanded Prospecting Agent, updates to Customer Agent ...

GSK Plc is planning five simultaneous late-stage trials for a cancer drug it hopes will be a blockbuster, as new Chief Executive Officer Luke Miels tries to revitalize a company not known for its risk ...